Senior insider sale
Chief Scientific Officer at LUMOS PHARMA, INC. — senior position signals high conviction
$1.4K
438.00 shares
What this filing means
MCKEW JOHN C. plans to sell 438.00 shares of LUMOS PHARMA, INC. valued at approximately $1.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/6/2024ACC: 0001967940-24-000010
Officer· Chief Scientific Officer
Since Mar 2020
438.00
Shares to sell
$1.4K
Approx. market value
438.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU
Cash
2/6/2024
438.00Total acquired438.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/6/2024 | RSU Cash | 438.00 | — |
| Total | 438.00 | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
438.00
Market value
$1.4K
2/6/2024
Total
Units
438.00
Value
$1.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/6/2024 | 438.00 | $1.4K | Nasdaq | Planned |
| Total | 438.00 | $1.4K | ||